Catalyst Pharm Inc (CPRX)

$5.90 0.00 (0.00%)

16:00 EDT CPRX Stock Quote Delayed 30 Minutes

7 Penny Stocks That Wall Street Thinks Are Undervalued

By Mark Putrino, CMT Mar 11, 2021

These penny stocks have more than just a low price point. They have Wall Street analysts backing up those prices with high price targets.

7 Penny Stock Companies That Actually Make Money

Despite Legal Drama, Catalyst Pharmaceuticals Looks Oversold

Why Catalyst Pharmaceuticals Stock Is Feeling the ‘Bern’

More Articles

Volume:

Previous Close -

Market Cap 609.85M

PE Ratio 8.68

EPS 0.68

Volume (Avg. Vol.)

Day's Range 5.90 - 5.90

52-Week Range 2.88 - 5.99

Dividend & Yield N/A (N/A)

CPRX Stock Predictions, Articles, and Catalyst Pharm Inc News

From InvestorPlace
From the Web

9 Robinhood Stocks Flying Under the Radar

By Josh Enomoto, InvestorPlace Contributor Sep 14, 2020

Robinhood stocks have generated much attention this year, but here are some names that you may not have heard about.

4 Strong Buy Biotech Stocks With Upcoming FDA Decisions

By Harriet Lefton, Writer, TipRanks Oct 23, 2018

These biotech stocks have fast-approaching PDUFA dates. Biotechs can soar or plunge on FDA decisions. These four pharma stocks should soar.

26 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 19, 2016

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

23 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 12, 2016

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Stocks Celebrate GOP Win on Bipartisan Hopes

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 5, 2014

Now on the horizon: The ECB, payrolls and Friday's showdown between President Obama and congressional leaders.

5 Red-Hot Biotech Stocks to Buy

By Anthony Mirhaydari, InvestorPlace Market Strategist Oct 27, 2014

Investors have been chasing risk again, buying up biotech stocks. Here's our list of the best biotech stocks out there.

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts

From Benzinga Jun 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Catalyst Pharmaceuticals Insights: Return On Capital Employed

From Benzinga Jun 9, 2021

Looking at Q1, Catalyst Pharmaceuticals (NASDAQ:CPRX) earned $9.80 million, a 13.73% increase from the preceding quarter. Catalyst Pharmaceuticals's sales decreased to $30.20...

First Week of July 16th Options Trading For Catalyst Pharmaceuticals (CPRX)

From Market News Video May 21, 2021

Investors in Catalyst Pharmaceuticals Inc (CPRX) saw new options begin trading this week, for the July 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CPRX options chain for the new July 16th contracts and identified one put and one call contract of particular interest.

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying

From Benzinga May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics

From Benzinga May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO

From Benzinga May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...